HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts

BioNTech Starts Construction of Africa’s First mRNA Vaccine Manufacturing Plant

With the construction starting for BioNTech’s new plant in Kigali, Rwanda, Africa is finally getting its first mRNA vaccine manufacturing facility. Lower- and middle-income nations have not received enough COVID-19 vaccines since they’ve become available, especially nations in Africa. This new […]

more info 06/23/2022View Related Articles
Bookmark and Share

Enanta Sues Pfizer over Alleged Paxlovid Patent Infringement

Enanta Pharmaceuticals has filed a lawsuit against the pharma giant Pfizer over claims of patent infringement involving its COVID-19 treatment Paxlovid. The company claims Pfizer’s use of nirmatrelvir, a protease inhibor that makes up one half of Paxlovid, is in violation of several patents. Instead […]

more info 06/22/2022View Related Articles
Bookmark and Share

14 Million May Lose Health Insurance When Public Health Emergency Ends

The Families First Coronavirus Response Act of 2020 helped provide coverage to millions who lost their employer-provided health insurance during the pandemic. However, with the end of the public health emergency looming over the horizon, those citizens are set to lose the coverage provided by the […]

more info 06/21/2022View Related Articles
Bookmark and Share

Pharma Facing Pressure to Renegotiate COVID-19 Vaccine Contracts with EU Govts

  As the demand for COVID-19 vaccines dwindle in Europe, many EU nations’ governments look to renegotiate their vaccine deals with manufacturers to reduce the doses they will purchase in the upcoming months. Manufacturers have resisted such requests, with Pfizer describing a letter from […]

more info 06/17/2022View Related Articles
Bookmark and Share

Breaking: US FDA Approves Moderna and Pfizer’s COVID-19 Vaccines for Children 5 and Under

The US Food and Drug Administration’s (FDA) vaccine advisory committee (Adcomm) voted unanimously (21-0) to approve Moderna and Pfizer’s mRNA-based COVID-19 vaccines for children aged 5 and under. The anticipated approval was urged by many in the healthcare community due to the increasing numbers of […]

more info 06/15/2022View Related Articles
Bookmark and Share

FDA Vocalizes Support for Moderna and Pfizer Vaccines for Children Under 5 One Day Before Advisory Committee

The US Food and Drug Administration (FDA) has signalled support for authorizing the Moderna and Pfizer COVID-19 vaccines for children under the age of 5 just one day before the agency’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is set to meet. The recommended authorization […]

more info 06/13/2022View Related Articles
Bookmark and Share

Novavax COVID-19 Vaccine Awaits FDA Review of Manufacturing Data

On Tuesday, outside experts at the US Food and Drug Administration (FDA) voted 21 – 0 to give emergency approval to Novavax’s COVID-19 vaccine. Unlike every other approved COVID-19 vaccine, however, the company’s vaccine has yet to be formally approved by the agency two days later. The other […]

more info 06/09/2022View Related Articles
Bookmark and Share

Call for Abstracts: Health Affairs Article Cluster: COVID-19 – Lessons For Public Health And Practice

Health Affairs is seeking submissions for its March 2023 journal focusing on the lessons that can be gleaned from changes public health policy and practice during the COVID-19 pandemic. In particular, the journal requests papers examining the effect of public health policy through comparative […]

more info 06/08/2022View Related Articles
Bookmark and Share

Emergent and J&J Butt Heads Over Breaches of Contract

On Monday, June 6th, Emergent BioSolutions informed Johnson & Johnson that it will owe $420 million if the company terminates their COVID-19 vaccine manufacturing contract. A representative from J&J contested these claims, stating that Emergent breached its end of the contract when it made […]

more info 06/07/2022View Related Articles
Bookmark and Share

The Economic Impact of COVID-19 on Healthcare Systems

A recently posted preprint systematic review in medRxiv has assessed the economic impact of the COVID-19 pandemic on healthcare systems and society worldwide. The researchers filtered over 10,000 papers, selecting 41 of them for economic analysis. Data from several countries and provinces showed […]

more info 06/06/2022View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 46
  • Next Page

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Manager, Statistical Analytics
  • Director / Senior Director, RWE
  • Research Analyst
  • Medical Writer
  • Associate Director/Director, Business Development
 
Syndicated Reports

Economic & Related Consulting Service Revenues World Report & Database

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories

Risk-Based Monitoring Software Market Worth $511 Million By 2025 – Growing Number Of Clinical Trials To Propel Market Growth

Real-World Evidence Solutions Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

 
White Papers

The Augmented Rep: A practical field force guide for the Omnichannel era

Rare Disease’s Star Turn

The Next Generation of Information Management

Risk Mitigation for Pharma Manufacturer Programs

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts